Ibrahim M. Idris

Also affiliated with Aminu Kano Teaching Hospital, Bayero University Kano

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks”.

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Blood(2024)10.1182/blood-2024-204962

N/A

0.312DataRank · unranked

7 citations

Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen +7 more

Sickle cell disease as an accelerated aging syndrome

Experimental Biology and Medicine(2022)10.1177/15353702211068522

N/A

0DataRank · unranked

35 citations

Edward A. Botchwey, Hyacinth I. Hyacinth, Ibrahim M. Idris